Skip to main content
18 February 2019
Last updated:
Monday 18 February 2019

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Nightstar reports positive early data for gene therapy

Monday 24 September 2018
Country

United Kingdom

Nightstar Therapeutics Plc has reported positive Phase 1/2 data from a trial of its gene therapy for X-linked retinitis pigmentosa, a rare inherited retinal disorder primarily affecting males.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Clinical Research
Company News

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Donato Spota to become CFO at Hansa Biopharma
Thursday February 7 2019
Georgia Gavriilidou joins Sidley Austin
Thursday February 7 2019
Alan Knox becomes CEO at Primex
Thursday February 7 2019
Kiadis appoints Robert Friesen as CSO
Thursday February 7 2019
Samantha Paston to head research at Scancell
Thursday February 7 2019

© 2018 Evernow Publishing Ltd. Powered by Drupal.